Endovia Health Sciences, Inc. short interest in 2024
In 2024, Endovia Health Sciences, Inc.'s disclosed short interest ran from 0.68% of shares outstanding on 12 Jan 2024 to 0.24% on 31 Dec 2024, a change of -0.44 percentage points. The year's high was 1.09% on 28 Jun 2024 and its low 0.21% on 13 Dec 2024, averaging 0.59% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.71 days on 12 Jan 2024. Full history: Endovia Health Sciences, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 0.68% (12 Jan 2024)
- End of year
- 0.24% (31 Dec 2024)
- Change
- -0.44 pp
- High
- 1.09% (28 Jun 2024)
- Low
- 0.21% (13 Dec 2024)
- Average
- 0.59%
- Highest days to cover
- 3.71 (12 Jan 2024)
- SEC filings marked
- 4
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 0.68% | 3.71 | |
| 31 Jan 2024 | 0.91% | 1.73 | |
| 15 Feb 2024 | 0.93% | 1.63 | |
| 29 Feb 2024 | 0.93% | 3.06 | |
| 15 Mar 2024 | 0.54% | 1.04 | |
| 28 Mar 2024 | 0.45% | 1.85 | |
| 15 Apr 2024 | 0.31% | 1.00 | 10-K filed |
| 30 Apr 2024 | 0.51% | 1.61 | |
| 15 May 2024 | 0.56% | 1.93 | 10-Q filed |
| 31 May 2024 | 0.80% | 1.00 | |
| 14 Jun 2024 | 0.89% | 1.00 | |
| 28 Jun 2024 | 1.09% | 1.00 | |
| 15 Jul 2024 | 0.78% | 1.00 | |
| 15 Aug 2024 | 0.56% | 1.00 | 10-Q filed |
| 30 Aug 2024 | 0.38% | 1.00 | |
| 13 Sep 2024 | 0.30% | 1.00 | |
| 30 Sep 2024 | 0.61% | 1.24 | |
| 15 Oct 2024 | 0.73% | 1.00 | |
| 31 Oct 2024 | 0.39% | 1.00 | |
| 15 Nov 2024 | 0.44% | 1.00 | 10-Q filed |
| 29 Nov 2024 | 0.40% | 1.00 | |
| 13 Dec 2024 | 0.21% | 1.00 | |
| 31 Dec 2024 | 0.24% | 1.00 |
See also: Endovia Health Sciences, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.